Hamish Jolly had been highlighting their position as not wanting to dilute themselves/shareholders. They had initiated this $200m financing mandate with Planum partners in August 2021, but I am unaware of any updates (anyone else know?). Even though the cash flow statement from 1H22 was disappointing - costs to suppliers going up, draining their cash - it appeared that most of that was pre-payment for PPE that would be repaid in future periods, as noted in the P&L statement. Considering they have no debt and around $4m at 31 December 2021, they shouldn't need to cap raise for operational expenses, unless they are unable to get debt financing ??
Hmm, maybe it's operational expenditures.. but I won't be surprised if their is a CAPEX component to this. New project, acquisition, etc. I am not trying to be a blinded bull, just seems a simple capital raise is incongruous with the Deloreans financial situation. Let's wait and see.
DEL Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
